Triazolam is a pharmaceutical raw material used as an active pharmaceutical ingredient in the manufacturing of sedative-hypnotic medications. It has a complex ring-containing structure and is associated with developmental toxicity according to government labeling requirements.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 28911-01-5
Alprazolam
active pharmaceutical ingredient
Ethyl 3-((2-((4-(N-hexoxycarbonylcarbamimidoyl)-N-nitrosoanilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoate
impurity standard for dabigatran etexilate
Delorazepam
active pharmaceutical ingredient
Apalutamide Di-(2-fluoro-N-methylbenzamide)
active pharmaceutical ingredient impurity
Canertinib dihydrochloride
active pharmaceutical ingredient
Alpha-Hydroxytriazolam
triazolobenzodiazepine metabolite
8-Chloro-6-(2-chlorophenyl)-1-ethenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
active pharmaceutical ingredient
4-Hydroxytriazolam
n.a
8-chloro-6-(2-chlorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine
JOFWLTCLBGQGBO-UHFFFAOYSA-N
CC1=NN=C2N1C3=C(C=C(C=C3)Cl)C(=NC2)C4=CC=CC=C4Cl